Target intelligence / Profile preview

Intestinal viscosity

Molecular classification
Other (not a molecule, receptor, enzyme, transporter, or gene)
01

Overview

Intestinal viscosity refers to the physical property describing the resistance to flow within gastrointestinal contents—primarily influenced by water-soluble dietary fibers that form viscous solutions when hydrated. It is not a discrete molecular target but rather an emergent property resulting from interactions among dietary components (especially soluble polysaccharides), digestive secretions, and microbial metabolites throughout different regions of the gastrointestinal tract. Increased intestinal viscosity can slow gastric emptying rate and reduce mixing between nutrients and digestive enzymes/bile acids in the small intestine—thereby limiting digestion efficiency and absorption rates for some nutrients such as fats and carbohydrates. In contrast, high colonic viscosity forms a physical barrier protecting mucosa from pathogens while also shaping microbiome composition through selective substrate availability for fermentation. The physiological effects depend on both magnitude/location along the tract and underlying health status; thus "intestinal viscosity" is best understood as an important functional parameter modulated by diet rather than a classical therapeutic target like receptors or enzymes.

Other names
Gut viscosityDigesta viscosityIntestinal content viscosity
02

Mechanism of action

Not applicable in the context of drug-target interaction. Dietary fibers increase intestinal viscosity by forming gels or thickening the chyme; this slows gastric emptying, modulates nutrient diffusion/absorption rates, alters bile acid reabsorption, and impacts microbial fermentation patterns.

03

Biological functions

Modulation of nutrient absorptionRegulation of gut motility and transit timePhysical barrier to pathogens in the colonInfluence on gut microbiota composition and fermentation
04

Disease associations

Obesity and metabolic disorders (via dietary fiber modulation)Gastrointestinal diseases (e.g., bacterial overgrowth)Malabsorption syndromes (by affecting nutrient uptake)
05

Safety considerations

Excessive increases can impair nutrient absorption leading to malnutrition or deficiencies in vulnerable populations (e.g., infants or those with GI disease)High-viscosity diets may cause bloating or altered bowel habits
06

Interacting drugs

Guar gum

4 more in the full profile.

07

Biomarkers

Viscosity measurements of digesta/chyme at various gut segmentsShort-chain fatty acid levels as markers for fiber fermentation efficacy

Beyond the preview

Go deeper on Intestinal viscosity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal viscosity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call